BR112013032354A2 - Composições e métodos para diagnóstico e monitoração de hipertireoidismo em um felino - Google Patents

Composições e métodos para diagnóstico e monitoração de hipertireoidismo em um felino

Info

Publication number
BR112013032354A2
BR112013032354A2 BR112013032354A BR112013032354A BR112013032354A2 BR 112013032354 A2 BR112013032354 A2 BR 112013032354A2 BR 112013032354 A BR112013032354 A BR 112013032354A BR 112013032354 A BR112013032354 A BR 112013032354A BR 112013032354 A2 BR112013032354 A2 BR 112013032354A2
Authority
BR
Brazil
Prior art keywords
feline
hyperthyroidism
compositions
methods
expression
Prior art date
Application number
BR112013032354A
Other languages
English (en)
Inventor
Al-Murrani Samer
Gao Xiangming
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of BR112013032354A2 publication Critical patent/BR112013032354A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/046Thyroid disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Abstract

COMPOSIÇÕES E MÉTODOS PARA DIAGNÓSTICO E MONITORAÇÃO DE HIPERTIREOIDISMO EM UM FELINO. A presente invenção fornece um método de diagnóstico da existência ou do risco de hipertireoidismo em um felino compreendendo determinação do nível de expressão de um ou mais biomarcadores selecionados do grupo que consiste em, por exemplo, IYD, TG, SLC5A5, NIS, TPO, TSHR, DUOX1, DUOX2 (ThOX), TGFB1, CSTD, DCN E SEPP1, e da expressão de seus produtos, em uma amostra biológica do felino, em que a expressão elevada de um ou mais biomarcadores na amostra em relação a um valor controle para expressão em uma amostra de um felino normal ou de uma população felina, ou a um valor basal do felino, indica a existência ou o risco de hipertireoidismo; um método de tratamento de um felino assim diagnosticado; e composições, reagentes e kits para realização dos métodos especificados.
BR112013032354A 2011-06-15 2012-06-14 Composições e métodos para diagnóstico e monitoração de hipertireoidismo em um felino BR112013032354A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161497264P 2011-06-15 2011-06-15
PCT/US2012/042534 WO2012174294A1 (en) 2011-06-15 2012-06-14 Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline

Publications (1)

Publication Number Publication Date
BR112013032354A2 true BR112013032354A2 (pt) 2017-01-03

Family

ID=46420541

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013032354A BR112013032354A2 (pt) 2011-06-15 2012-06-14 Composições e métodos para diagnóstico e monitoração de hipertireoidismo em um felino

Country Status (10)

Country Link
US (3) US10144969B2 (pt)
EP (1) EP2721175B1 (pt)
JP (1) JP5930556B2 (pt)
CN (1) CN103597097B (pt)
AU (1) AU2012271528B2 (pt)
BR (1) BR112013032354A2 (pt)
CA (1) CA2839207A1 (pt)
RU (1) RU2593952C2 (pt)
WO (1) WO2012174294A1 (pt)
ZA (1) ZA201309124B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2859149A1 (en) * 2011-12-19 2013-06-27 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
EP2822457A4 (en) * 2012-03-09 2015-11-11 Basf Se MEANS AND METHODS FOR ASSESSING HYPERTHYROIDISM
EP3136101B1 (en) * 2014-04-22 2019-12-25 Tohoku University Method of testing for pulmonary hypertension
CN104120186B (zh) * 2014-08-06 2017-07-11 广西壮族自治区妇幼保健院 先天性甲状腺功能减低症多基因测序引物及检测方法
CN105695616A (zh) * 2016-04-22 2016-06-22 王冬国 诊断甲状腺癌的分析标志物及其应用
CN108410976A (zh) * 2018-03-19 2018-08-17 上海交通大学医学院附属第九人民医院 针对先天性甲减的靶向二代测序的基因芯片
EP4022089A1 (en) * 2019-12-18 2022-07-06 Hill's Pet Nutrition, Inc. Methods for identifying a companion animal at risk of calcium oxalate stone formation and treatments and compositions for reducing the risk
EP3969611A1 (en) * 2020-02-03 2022-03-23 Illumina, Inc. Biotin-streptavidin cleavage composition and library fragment cleavage
RU2766668C1 (ru) * 2021-05-11 2022-03-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Белгородский государственный аграрный университет имени В.Я. Горина" Способ диагностики заболеваний щитовидной железы у кошек

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1359801A (en) 1920-03-03 1920-11-23 Goldner Joe Combination mattress and pillow
US4437975A (en) 1977-07-20 1984-03-20 Mobil Oil Corporation Manufacture of lube base stock oil
US5242794A (en) 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US5333675C1 (en) 1986-02-25 2001-05-01 Perkin Elmer Corp Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
CA1340843C (en) 1987-07-31 1999-12-07 J. Lawrence Burg Selective amplification of target polynucleotide sequences
JP2650159B2 (ja) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー 核酸増幅方法
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
BR8907830A (pt) 1988-12-16 1991-10-22 Siska Diagnostics Inc Processo para preparar uma dna de filamento duplo que codifica uma sequencia que corresponde a uma sequencia objetivada de acido nucleico e processo util para deteccao de pelo menos uma sequencia de acido nucleico objetivada especifica
US5856092A (en) 1989-02-13 1999-01-05 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5871928A (en) 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
JPH06500471A (ja) 1990-08-24 1994-01-20 ザ・ユニバーシティ・オブ・テネシー・リサーチ・コーポレーション Dna増幅フィンガープリント法
WO1992007095A1 (en) 1990-10-15 1992-04-30 Stratagene Arbitrarily primed polymerase chain reaction method for fingerprinting genomes
JPH0536586A (ja) 1991-08-02 1993-02-12 Canon Inc 像投影方法及び該方法を用いた半導体デバイスの製造方法
CA2124087C (en) 1991-11-22 2002-10-01 James L. Winkler Combinatorial strategies for polymer synthesis
US5541061A (en) 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
DE69431719T2 (de) 1993-06-25 2003-09-18 Affymetrix Inc N D Ges D Staat Hybridisierung und sequenzierung von nukleinsäuren
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US6090555A (en) 1997-12-11 2000-07-18 Affymetrix, Inc. Scanned image alignment systems and methods
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6300063B1 (en) 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
US6114122A (en) 1996-03-26 2000-09-05 Affymetrix, Inc. Fluidics station with a mounting system and method of using
JP2000512744A (ja) 1996-05-16 2000-09-26 アフィメトリックス,インコーポレイテッド 標識材料を検出するシステムおよび方法
US6368799B1 (en) 1997-06-13 2002-04-09 Affymetrix, Inc. Method to detect gene polymorphisms and monitor allelic expression employing a probe array
US6333179B1 (en) 1997-06-20 2001-12-25 Affymetrix, Inc. Methods and compositions for multiplex amplification of nucleic acids
EP1027456B1 (en) 1997-10-31 2005-03-16 Affymetrix, Inc. (a Delaware Corporation) Expression profiles in adult and fetal organs
US6013449A (en) 1997-11-26 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Probe-based analysis of heterozygous mutations using two-color labelling
US6201639B1 (en) 1998-03-20 2001-03-13 James W. Overbeck Wide field of view and high speed scanning microscopy
US6185030B1 (en) 1998-03-20 2001-02-06 James W. Overbeck Wide field of view and high speed scanning microscopy
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US5936324A (en) 1998-03-30 1999-08-10 Genetic Microsystems Inc. Moving magnet scanner
US6361947B1 (en) 1998-10-27 2002-03-26 Affymetrix, Inc. Complexity management and analysis of genomic DNA
US6177248B1 (en) 1999-02-24 2001-01-23 Affymetrix, Inc. Downstream genes of tumor suppressor WT1
US6218803B1 (en) 1999-06-04 2001-04-17 Genetic Microsystems, Inc. Position sensing with variable capacitance transducers
US6300070B1 (en) 1999-06-04 2001-10-09 Mosaic Technologies, Inc. Solid phase methods for amplifying multiple nucleic acids
US6958225B2 (en) 1999-10-27 2005-10-25 Affymetrix, Inc. Complexity management of genomic DNA
US6582938B1 (en) 2001-05-11 2003-06-24 Affymetrix, Inc. Amplification of nucleic acids
RU2187954C2 (ru) * 2000-03-21 2002-08-27 Архангельская государственная медицинская академия Способ диагностики гипертиреоза
US6386749B1 (en) 2000-06-26 2002-05-14 Affymetrix, Inc. Systems and methods for heating and mixing fluids
US6391592B1 (en) 2000-12-14 2002-05-21 Affymetrix, Inc. Blocker-aided target amplification of nucleic acids
US6632611B2 (en) 2001-07-20 2003-10-14 Affymetrix, Inc. Method of target enrichment and amplification
US6872529B2 (en) 2001-07-25 2005-03-29 Affymetrix, Inc. Complexity management of genomic DNA
CA2422224A1 (en) 2002-03-15 2003-09-15 Affymetrix, Inc. System, method, and product for scanning of biological materials
EP1362929A3 (en) 2002-05-17 2004-05-19 Affymetrix, Inc. Methods for genotyping
RU2352143C2 (ru) * 2003-06-20 2009-04-20 Хилл'С Пет Ньютришн, Инк. Композиции и способы для восстановления функции щитовидной железы у кошек
EP1986508B1 (en) 2006-01-26 2014-05-21 Hill's Pet Nutrition, Inc. Methods and compositions for treating feline hyperthyroidism
RU2504586C2 (ru) * 2007-05-01 2014-01-20 Хилл'С Пет Ньютришн, Инк. Способы и композиции для диагностики остеоартрита у животного семейства кошачьих

Also Published As

Publication number Publication date
CN103597097A (zh) 2014-02-19
ZA201309124B (en) 2016-08-31
CA2839207A1 (en) 2012-12-20
US10704103B2 (en) 2020-07-07
US10144969B2 (en) 2018-12-04
EP2721175A1 (en) 2014-04-23
AU2012271528B2 (en) 2015-06-25
US20190078163A1 (en) 2019-03-14
AU2012271528A1 (en) 2013-05-02
EP2721175B1 (en) 2015-09-16
RU2014101058A (ru) 2015-07-20
US20150118155A1 (en) 2015-04-30
JP5930556B2 (ja) 2016-06-08
JP2014519341A (ja) 2014-08-14
CN103597097B (zh) 2016-08-17
WO2012174294A1 (en) 2012-12-20
RU2593952C2 (ru) 2016-08-10
US10704102B2 (en) 2020-07-07
US20190071728A1 (en) 2019-03-07

Similar Documents

Publication Publication Date Title
BR112013032354A2 (pt) Composições e métodos para diagnóstico e monitoração de hipertireoidismo em um felino
BR112014007214A2 (pt) predição de evento de risco cardiovascular e utilização do mesmo
Müezzinler et al. Smoking habits and leukocyte telomere length dynamics among older adults: results from the ESTHER cohort
Cardenas et al. Prenatal exposure to mercury: associations with global DNA methylation and hydroxymethylation in cord blood and in childhood
Meganathan et al. Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells
CN106460028B (zh) 细胞的分化状态的评价方法
BR112014006432A2 (pt) biomarcadores do câncer de pulmão e seus usos
BR112019003704A2 (pt) métodos para a detecção de alterações na cópia genômica em amostras de dna
Kochmanski et al. Longitudinal effects of developmental bisphenol A and variable diet exposures on epigenetic drift in mice
BR112012015693A8 (pt) métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda
BR112013003391B8 (pt) Método para diagnosticar câncer pancreático em um indivíduo
Cătoi et al. Increased chemerin and decreased omentin-1 levels in morbidly obese patients are correlated with insulin resistance, oxidative stress and chronic inflammation
Li et al. The catalytic subunit of DNA-dependent protein kinase is required for cellular resistance to oxidative stress independent of DNA double-strand break repair
BR112014012061A2 (pt) Método para detectar a presença de bactérias de produção de beta-lactamase de espectro expandido em uma amostra
BR112015024780A2 (pt) metodo para determinar radiosensibilidade
ATE517342T1 (de) Schnelle beurteilung von leiden der oberen atemwege
Tomsič et al. Plasma total antioxidant capacity and activities of blood glutathione peroxidase and superoxide dismutase determined in healthy dogs by using commercially available kits
BR112022007996A2 (pt) Métodos para o tratamento e uso de biomarcadores para predizer a sensibilidade clínica à 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida
Huen et al. DNA methylation of LINE-1 and Alu repetitive elements in relation to sex hormones and pubertal timing in Mexican-American children
England-Mason et al. Prenatal exposure to phthalates and peripheral blood and buccal epithelial DNA methylation in infants: an epigenome-wide association study
Goodrich et al. Prenatal exposures and DNA methylation in newborns: a pilot study in Durban, South Africa
O’Flaherty Iatrogenic genetic damage of spermatozoa
BR112017021318A2 (pt) método implementado por computador, e mídia legível por computador
BR112017003778A2 (pt) compostos contra ralstonia pickettii para o uso no tratamento de resistência à insulina e método de diagnóstico de resistência à insulina
CA2922105A1 (en) Systems and methods for determining impact of age related changes in sperm epigenome on offspring phenotype

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]